S. Peter Ludwig is a Principal in the New York office of Fish & Richardson. Mr. Ludwig’s practice is focused on domestic and foreign patent prosecution, litigation, licensing, interference and counseling issues, particularly in representing high-tech start-up companies and academic institutions. His technical expertise includes biotechnology (vaccines, functional genomics, pharmacogenomics, high throughput screening, stem cell technology, autoimmune diseases, gene therapy), pharmaceuticals (neuroleptic drugs, drug delivery systems, anti-metabolites, natural pharmaceuticals, anti-tumor agents, anti-viral agents), medical devices, photo-chemistry, paper chemistry, medical rubber products, aluminum processing and diagnostic products.
Mr. Ludwig has spoken on intellectual property issues for numerous professional associations, including the American Chemical Society, Pharmaceutical Research and Manufacturers of America, the New York Biotechnology Association, the Association of the Bar of the City of New York, the Biotechnology Industry Association, the Genetics Policy Institute, The American Conference Institute and the New York Intellectual Property Law Association.
Under an Ampart grant from the United States State Department, Mr. Ludwig lectured and advised government authorities and industry representatives in Brazil on strengthening intellectual property rights for biotechnology and pharmaceuticals.
From 2001 to 2005, Mr. Ludwig served as a speaker and as the chair or co-chair of the annual Biotechnology and Pharmaceutical Law and Business Program sponsored by the Practising Law Institute in New York and San Francisco. Mr. Ludwig was the Chair of the New York Intellectual Property Law Association’s Patentable Subject Matter Committee for the 2009-2010 term.